The Lung Health Study

Idiopathic pulmonary fibrosis (IPF) is a lung disease that causes scarring and damage to the lungs, leading to difficulty in breathing. The exact cause of IPF is unknown but it is hoped
this research will aid in slowing down the progression of the disease.

Current treatments have significant side effects or are not very effective. This incredible study is dedicated to finding a solution - more effective with fewer side effects in comparison.

The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.

Call us on 1800 243 733 to discuss your eligibility today!